Table 1.
Characteristics | Overall (n = 103) | Pyelonephritis (n = 36) | Cystitis (n = 67) | P-value | |||
---|---|---|---|---|---|---|---|
% | (95 % CI) | % | (95 % CI) | % | 95 % CI) | ||
Race/ethnicity | |||||||
Black, non-Hispanic | 51.5 | (41.4–61.4) | 55.6 | (38.1–72.1) | 49.3 | (36.8–61.8) | 0.74 |
White, non-Hispanic | 31.1 | (22.3–40.9) | 30.6 | (16.3–48.1) | 31.3 | (20.6–43.8) | |
Hispanic or other race | 17.5 | (10.7–26.2) | 13.9 | (4.7–29.5) | 19.4 | (10.8–30.9) | |
Age, y | |||||||
18–29 | 64.1 | (54.0–73.3) | 47.2 | (30.4–64.5) | 73.1 | (60.9–83.2) | <0.01 |
30–39 | 25.2 | (17.2–34.8) | 44.4 | (27.9–61.9) | 14.9 | (7.4–25.7) | |
40+ | 10.7 | (5.5–18.3) | 8.3 | (1.8–22.5) | 11.9 | (5.3–22.2) | |
Clinical history | |||||||
Sexually active | 83.5 | (74.9–90.1) | 77.8 | (60.8–89.9) | 86.6 | (76.0–93.7) | 0.25 |
No recent history of UTI | 38.8 | (29.4–48.9) | 36.1 | (20.8–53.8) | 40.3 | (28.5–53.0) | 0.68 |
Clinical symptoms | |||||||
Dysuria | 78.6 | (69.5–86.1) | 75.0 | (57.8–87.9) | 80.6 | (87.5–99.1) | 0.51 |
Frequent urination | 83.5 | (74.9–90.1) | 83.3 | (67.2–93.6) | 83.6 | (72.5–91.5) | 0.97 |
Decreased urine output | 37.9 | (28.5–48.0) | 47.2 | (30.4–64.5) | 32.8 | (21.8–45.4) | 0.15 |
Nausea/vomiting | 20.4 | (13.1–29.5) | 36.1 | (20.8–53.8) | 11.9 | (5.3–22.2) | <0.01 |
Vaginal discharge | 13.6 | (7.6–21.8) | 11.1 | (3.1–26.1) | 14.9 | (7.4–25.7) | 0.59 |
Abdominal pain | 54.4 | (44.3–64.2) | 75.0 | (57.8–87.9) | 43.3 | (31.2–56.0) | <0.01 |
Back pain | 42.7 | (33.0–52.8) | 69.4 | (51.9–83.7) | 28.4 | (18.0–40.7) | <0.01 |
Onset of symptoms | |||||||
< 4 days | 60.8 | (50.6–70.3) | 41.7 | (25.5–59.2) | 71.2 | (58.7–81.7) | 0.01 |
4–7 days | 29.4 | (20.8–39.3) | 41.7 | (25.5–59.2) | 22.7 | (13.3–34.7) | |
> 7 days | 9.8 | (4.8–17.3) | 16.7 | (6.4–32.8) | 6.1 | (1.7–14.8) |
P-Values that appear in bold are significant at p < 0.05